Patent Assignment
Reel/Frame 059652/0335
Assignment of Assignor's Interest
Recorded: 2022-04-20
Pages: 5
Assignee
INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET, SUITE 900, NEW YORK, NEW YORK, 10016
Covered Properties
(3)
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals
4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)-1-(4-FLUOROPHENYL)-1-BUTANONE TOLUENESULFONIC ACID SALT CRYSTAL FORMS
4-((6bR,10aS)-3-METHYL-2,3,6b,9,10,10a-HEXAHYDRO-1H-PYRIDO[3',4':4,5]PYRROLO[1,2,3-de]QUINOXALIN-8(7H)-YL)-1-(4-FLUOROPHENYL)-1-BUTANONE TOLUENESULFONIC ACID SALT CRYSTAL FORMS
Patent:
48,825 →
Application:
16/294,607 →